Insiders RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Market Closed - OTC Markets Other stock markets 14:26:13 2024-05-14 EDT			5-day change	1st Jan Change
0.00096 ^USD	+1.05%		+11.11%	+11.11%

04-10	RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding	CI
03-20	RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RespireRx Pharmaceuticals Inc. Announces the Appointment of Dariusz Naziek to its Board of Directors	01-22	CI
Respirerx Pharmaceuticals Inc. Announces Appointment of Joseph Siegelbaum as Independent Member of the Board of Directors	23-03-28	CI
RespireRx Pharmaceuticals Inc. Announces Board Changes	22-08-03	CI
RespireRx Pharmaceuticals Inc. Announces Board Changes	22-01-10	CI
RespireRx Pharmaceuticals Inc. Announces CEO Changes	22-01-10	CI
RespireRx Pharmaceuticals Inc. Appoints David Dickason as Senior Vice President Pre-Clinical Product Development	20-09-25	CI
RespireRx Pharmaceuticals Inc. Announces Appointment of Timothy Jones as President and Chief Executive Officer	20-05-06	CI
RespireRx Pharmaceuticals Inc. Announces the Appointment of Tim Jones to its Board of Directors	20-02-03	CI
Respirerx Pharmaceuticals Inc. Announces Resignation of James Sapirstein as Board of Directors and Other Committees	19-12-30	CI
RespireRx Pharmaceuticals Inc. Appoints James Sapirstein as Executive Vice Chairman of the Board of Directors	19-01-03	CI
RespireRx Pharmaceuticals Inc. Announces Resignation of James S. Manuso as President, CEO, Vice Chairman and Member of the Board of Directors, Effective September 30, 2018	18-06-19	CI
RespireRx Pharmaceuticals Inc. Announces appoints Jeff Eliot Margolis as chief financial officer and senior vice president	17-07-07	CI
RespireRx Pharmaceuticals Inc. Announces Management Changes	17-02-23	CI
Cortex Pharmaceuticals, Inc. has Changed its Name to RespireRx Pharmaceuticals Inc	15-12-16	CI
Cortex Pharmaceuticals, Inc. Announces Management Changes	15-08-19	CI
Cortex Pharmaceuticals, Inc. Names John Greer as Chairman of the Scientific Advisory Board	14-09-24	CI
Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors	14-09-04	CI
Cortex Pharmaceuticals Inc. Announces Resignation of Moogak Hwan from the Board of Directors	13-10-04	CI
Cortex Pharmaceuticals Inc. Management Changes	13-05-03	CI
Cortex Pharmaceuticals Inc. Announces Executive Changes	13-03-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Insiders

Filters